SWVa. Technology Council selects director
Return to top
ABINGDON - The Southwestern Virginia Technology Council (SWVTC) has selected Esther W. Bolling as its new executive director. Bolling has been a member of the SWVTC board of directors for three years and has served as treasurer for two years. Bolling has filled executive positions in the banking industry including vice president, chief financial officer and chief information officer, and most recently held the post of executive director for the Mountain Empire Electronic Business Village, where she remains an active member of the board of directors. She also owns her own financial consulting firm. The Southwestern Virginia Technology Council was established in 1999 and includes the 13 counties southwest of Roanoke stretching from Carroll to Lee County. The council's mission is to lead Southwest Virginians in addressing technology issues for business, education and government with the purpose of enhancing the vitality and social well-being of Southwest Virginia.
Gregory joins Stellar board
Return to top
ONTARIO - Stellar Pharmaceuticals Inc., a Canadian pharmaceutical developer and marketer, on Monday announced that John M. Gregory, former CEO of Bristol, Tenn.-based King Pharmaceuticals, has agreed to join the Stellar board as a new director. Gregory is the founder and managing partner of SJ Strategic Investments LLC, which is the largest shareholder of Stellar, holding 5.19 million shares which represents approximately 21.8 percent of the company's shares on a non-diluted basis. "I am honored to become a member of the board of Stellar. I hope to utilize my experience and contacts in the pharmaceutical industry to assist Stellar with its strategic initiatives. Since leaving King Pharmaceuticals, I have passed on joining the boards of several publicly traded companies. I accepted this post due to my strong belief in Stellar's management and the future potential of the company," Gregory said. Arnold Tenney, Stellar's chairman of the board, said, "As the founder and former chairman and chief executive officer of King Pharmaceuticals, Mr. Gregory created the specialty pharmaceutical growth-by-acquisition model and grew King into a company with revenues exceeding $1 billion, with various sites around the United States. We look forward to his contributions to our company as we continue to build value for our shareholders." Gregory's appointment is subject to approval of the TSX Venture Exchange.